Aktuelle Nachrichten
  • Sickle Cell Disease Patients‘ Views on Oxbryta
  • TIF’s Submission To The UK NICE’s Consultation Document For Zynteglo®
  • Time To Get Ready For Rare Disease Day 2021!
  • TIF’s Public Statement on Current Developments in Gene Therapy SCD Clinical Trials and Thalassaemia Gene Therapy Zynteglo
  • Publications
  • Meetings
  • NOW PUBLISHED: The TIF ‘’Gene Therapy & Thalassaemia’’ Survey Report
  • TIF.ACCESS Project
  • TIF’s Point of View: Medicines Regulatory Systems – Continued Strengthening Is Required
  • TIF Supports IAPO´s Call For The Ratification Of The African Medicines Agency Treaty
  • English
  • Ελληνικά
  • Français
  • Deutsch
  • Italiano
  • العربية
  • Menü
TIF

News und Events

Support us
  • Suchen nach
  • RSS
  • Instagram
  • YouTube
  • Twitter
  • Facebook

News

  • Alle
  • Clinical News
  • Member News
  • News
  • TIF News
  • SurveysBild von Sickle Cell Disease Patients‘ Views on Oxbryta
    6 Tagen vor

    Sickle Cell Disease Patients‘ Views on Oxbryta

    OXBRYTA (voxelotor) is a prescription medicine used for the treatment of sickle cell disease (SCD) and constitutes the first aproved…

    Weiterlesen »
  • NewsBild von TIF’s Submission To The UK NICE’s Consultation Document For Zynteglo®
    7 Tagen vor

    TIF’s Submission To The UK NICE’s Consultation Document For Zynteglo®

    On February 12, in an appraisal consultation document, the UK National Institute for Health and Care Excellence (NICE) recommended against the use…

    Weiterlesen »
  • Member NewsBild von Time To Get Ready For Rare Disease Day 2021!
    2 Wochen vor

    Time To Get Ready For Rare Disease Day 2021!

    TIF joins forces with 300 million people around the world for the global observance of Rare Disease Day, coming up…

    Weiterlesen »
  • Clinical NewsBild von TIF’s Public Statement on Current Developments in Gene Therapy SCD Clinical Trials and Thalassaemia Gene Therapy Zynteglo
    2 Wochen vor

    TIF’s Public Statement on Current Developments in Gene Therapy SCD Clinical Trials and Thalassaemia Gene Therapy Zynteglo

    The Thalassaemia International Federation (TIF) has been informed through official communication by both the European Medicines Agency (EMA) and bluebird…

    Weiterlesen »
  • NewsBild von Meetings
    3 Wochen vor

    Meetings

    Weiterlesen »
  • NewsBild von NOW PUBLISHED: The TIF ‘’Gene Therapy & Thalassaemia’’ Survey Report
    3 Wochen vor

    NOW PUBLISHED: The TIF ‘’Gene Therapy & Thalassaemia’’ Survey Report

    Gene therapy for thalassaemia is an expensive and complex procedure, with great efforts ongoing currently by all involved stakeholders, such…

    Weiterlesen »
  • NewsBild von TIF’s Point of View: Medicines Regulatory Systems – Continued Strengthening Is Required
    4 Wochen vor

    TIF’s Point of View: Medicines Regulatory Systems – Continued Strengthening Is Required

    Access to quality-assured medical products improves health and saves lives. Nevertheless, one third of the world’s population lacks timely access…

    Weiterlesen »
  • Member NewsBild von TIF Supports IAPO´s Call For The Ratification Of The African Medicines Agency Treaty
    4 Wochen vor

    TIF Supports IAPO´s Call For The Ratification Of The African Medicines Agency Treaty

    Two years after the Treaty to establish an African Medicines Agency was agreed, over 40 leading organizations, including the Thalassaemia…

    Weiterlesen »
  • Clinical NewsBild von The Lancet: Russian Coronavirus Sputnik V Vaccine Achieves Over 90% Efficacy
    Februar 3, 2021

    The Lancet: Russian Coronavirus Sputnik V Vaccine Achieves Over 90% Efficacy

    Russia’s Sputnik V vaccine was 91.6% effective in preventing people from developing Covid-19, according to peer-reviewed results from its late-stage…

    Weiterlesen »
Mehr laden
Quick links
  • Für Patienten
  • Für Fachkreise
  • Für Verbände
  • Für Unterstützer
  • Unsere Mitglieder
  • Nützliche Links
  • Sitemap
Subscribe to our newsletter

Follow us
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • RSS
© Copyright 2021, All Rights Reserved  |  Powered by Genestial
Transparency Statement | Privacy Policy
Schaltfläche "Zurück zum Anfang"
Schließen
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • RSS
Quick Links
  • For Patients
  • For Healthcare Professionals
  • For Associations
  • For Supporters
  • TIF Members
  • Useful Links
  • Sitemap
Schließen
Schließen
Anmelden
Vergessen?

Cookies

This site uses cookies. Find out more